Study Summary
This trial will study how beta-glucan, a type of dietary fiber, affects the immune system in people with melanoma.
- Melanoma Stage III
- Metastatic Melanoma
Treatment Effectiveness
Phase-Based Effectiveness
Study Objectives
6 Primary · 0 Secondary · Reporting Duration: Blood for analysis will be drawn at baseline (Day 0), 3 weeks post pembrolizumab treatment, and 3 weeks post pembrolizumab plus oral beta-glucan
Trial Safety
Phase-Based Safety
Awards & Highlights
Trial Design
1 Treatment Group
Treatment
1 of 1
Experimental Treatment
30 Total Participants · 1 Treatment Group
Primary Treatment: Beta-Glucan · No Placebo Group · N/A
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · All Participants · 2 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
How many participants are being monitored during this research endeavor?
"Affirmative. Information available on clinicaltrials.gov asserts that this medical trial, first posted back in November 2020, is currently recruiting participants at one site with a need for 30 patients." - Anonymous Online Contributor
Is recruitment currently underway for this experiment?
"Affirmative. Clinicaltrials.gov reveals that this trial was initially posted on November 3rd 2020, and is still actively recruiting participants with edits last made on January 7th 2022. 30 people need to be recruited at a single site in order for the study to continue." - Anonymous Online Contributor